Terminated NA INTERVENTIONAL 1-arm NCT02351726

Mitroflow DL Post Approval Study- North America

Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study

Sponsor: LivaNova

Conditions Aortic Regurgitation Aortic Stenosis Aortic Valve Insufficiency Cardiovascular Abnormalities Cardiovascular Diseases Congenital Abnormalities Heart Diseases Heart Valve Diseases Pathological Conditions, Anatomical

Interventions Mitroflow DL

Updated 10 times since 2017 Last updated: Feb 18, 2020 Started: Mar 31, 2015 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor business decision

Other terminated trials from LivaNova

See all terminations from LivaNova

Listed as NCT02351726, this NA trial focuses on Aortic Regurgitation and Aortic Stenosis and remains terminated or withdrawn. Sponsored by LivaNova, it has been updated 10 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Mar 2020 — Jan 2021 [monthly]

Terminated NA

Status: Active Not Recruiting → Terminated
Feb 2019 — Mar 2020 [monthly]

Active Not Recruiting NA

▶ Show 5 earlier versions

Jun 2018 — Feb 2019 [monthly]

Active Not Recruiting NA
Dec 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jun 2017 — Dec 2017 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Feb 2017 — Jun 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LivaNova

Data source: LivaNova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bay City, United States , Bethesda, United States , Charlottesville, United States , Detroit, United States , Durham, United States , Jacksonville, United States , Lakeland, United States , Los Angeles, United States , Manchester, United States , Paterson, United States and 2 more locations